U.S. markets open in 10 minutes

PTC Therapeutics: 4Q Earnings Snapshot

SOUTH PLAINFIELD, N.J. (AP) _ PTC Therapeutics Inc. (PTCT) on Monday reported a loss of $77.7 million in its fourth quarter.

On a per-share basis, the South Plainfield, New Jersey-based company said it had a loss of $1.37. Losses, adjusted for non-recurring costs, came to $1.15 per share.

The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 53 cents per share.

The biopharmaceutical company posted revenue of $96.5 million in the period.

For the year, the company reported that its loss widened to $251.6 million, or $4.27 per share. Revenue was reported as $307 million.

PTC Therapeutics shares have climbed 14% since the beginning of the year. In the final minutes of trading on Monday, shares hit $54.93, a climb of 54% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PTCT at https://www.zacks.com/ap/PTCT